News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
672,228 Results
Type
Article (34042)
Company Profile (641)
Press Release (637545)
Multimedia
Podcasts (87)
Webinars (12)
Section
Business (203312)
Career Advice (2191)
Deals (37194)
Drug Delivery (109)
Drug Development (80673)
Employer Resources (167)
FDA (15772)
Job Trends (15038)
News (343951)
Policy (30277)
Tag
Academia (1338)
Academic (1)
Accelerated approval (5)
Adcomms (15)
Allergies (87)
Alliances (48968)
ALS (99)
Alzheimer's disease (1329)
Antibody-drug conjugate (ADC) (151)
Approvals (15748)
Artificial intelligence (269)
Autoimmune disease (29)
Automation (15)
Bankruptcy (380)
Best Places to Work (11062)
BIOSECURE Act (22)
Biosimilars (105)
Biotechnology (438)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (260)
Cancer (2184)
Cardiovascular disease (179)
Career advice (1809)
Career pathing (32)
CAR-T (154)
Cell therapy (446)
Cervical cancer (18)
Clinical research (66189)
Collaboration (881)
Company closure (2)
Compensation (564)
Complete response letters (29)
COVID-19 (2234)
CRISPR (48)
C-suite (268)
Cystic fibrosis (102)
Data (2217)
Decentralized trials (2)
Denatured (16)
Depression (52)
Diabetes (260)
Diagnostics (6369)
Digital health (18)
Diversity (3)
Diversity, equity & inclusion (38)
Drug discovery (117)
Drug pricing (111)
Drug shortages (27)
Duchenne muscular dystrophy (93)
Earnings (86004)
Editorial (41)
Employer branding (24)
Employer resources (142)
Events (113019)
Executive appointments (763)
FDA (17074)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (764)
Gene editing (119)
Generative AI (25)
Gene therapy (323)
GLP-1 (751)
Government (3075)
Grass and pollen (6)
Guidances (143)
Healthcare (16094)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (135)
Indications (29)
Infectious disease (2374)
Inflammatory bowel disease (145)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (99)
Interviews (435)
IPO (17370)
IRA (45)
Job creations (4417)
Job search strategy (1508)
Kidney cancer (10)
Labor market (42)
Layoffs (551)
Leadership (19)
Legal (7689)
Liver cancer (73)
Lung cancer (309)
Lymphoma (141)
Machine learning (6)
Management (59)
Manufacturing (349)
MASH (77)
Medical device (13589)
Medtech (13594)
Mergers & acquisitions (20397)
Metabolic disorders (705)
Multiple sclerosis (85)
NASH (21)
Neurodegenerative disease (105)
Neuropsychiatric disorders (32)
Neuroscience (1905)
NextGen: Class of 2025 (6038)
Non-profit (2037)
Now hiring (41)
Obesity (376)
Opinion (253)
Ovarian cancer (72)
Pain (103)
Pancreatic cancer (85)
Parkinson's disease (151)
Partnered (19)
Patents (249)
Patient recruitment (113)
Peanut (48)
People (58029)
Pharmaceutical (133)
Pharmacy benefit managers (18)
Phase I (20699)
Phase II (29463)
Phase III (21909)
Pipeline (1357)
Policy (150)
Postmarket research (2138)
Preclinical (8488)
Press Release (64)
Prostate cancer (104)
Psychedelics (36)
Radiopharmaceuticals (262)
Rare diseases (398)
Real estate (6028)
Recruiting (65)
Regulatory (21557)
Reports (36)
Research institute (1392)
Resumes & cover letters (342)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (79)
Series A (138)
Series B (94)
Service/supplier (26)
Sickle cell disease (55)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (22)
Startups (3939)
State (2)
Stomach cancer (14)
Supply chain (72)
Tariffs (54)
The Weekly (69)
Vaccines (673)
Venture capitalists (45)
Weight loss (255)
Women's health (26)
Worklife (20)
Date
Last 7 days (943)
Last 30 days (2989)
Last 365 days (32924)
2025 (11854)
2024 (35951)
2023 (40682)
2022 (51209)
2021 (54622)
2020 (51615)
2019 (42540)
2018 (32491)
2017 (33100)
2016 (31449)
2015 (36931)
2014 (30151)
2013 (25283)
2012 (26866)
2011 (27027)
2010 (25023)
Location
Africa (697)
Alabama (60)
Alaska (6)
Arizona (174)
Arkansas (11)
Asia (42946)
Australia (6871)
California (6481)
Canada (2055)
China (554)
Colorado (271)
Connecticut (286)
Delaware (150)
Europe (90412)
Florida (907)
Georgia (210)
Hawaii (1)
Idaho (56)
Illinois (485)
India (28)
Indiana (331)
Iowa (12)
Japan (169)
Kansas (102)
Kentucky (24)
Louisiana (12)
Maine (65)
Maryland (820)
Massachusetts (4985)
Michigan (239)
Minnesota (406)
Mississippi (2)
Missouri (80)
Montana (30)
Nebraska (22)
Nevada (62)
New Hampshire (66)
New Jersey (1811)
New Mexico (30)
New York (1781)
North Carolina (1091)
North Dakota (7)
Northern California (2815)
Ohio (193)
Oklahoma (10)
Oregon (41)
Pennsylvania (1395)
Puerto Rico (14)
Rhode Island (35)
South America (1098)
South Carolina (24)
South Dakota (1)
Southern California (2386)
Tennessee (85)
Texas (929)
United States (24026)
Utah (185)
Virginia (150)
Washington D.C. (62)
Washington State (582)
West Virginia (3)
Wisconsin (57)
672,228 Results for "taiho pharmaceutical company ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Taiho Pharmaceutical Buys ADC Partner Araris for up to $1.1B Total
Japan-based Taiho Pharmaceutical has worked with Araris Biotech since 2023 developing antibody-drug conjugates for the oncology space.
March 17, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech
March 17, 2025
·
7 min read
Press Releases
Taiho Oncology to Share Data in Five Presentations, Including Two Oral Presentations, at the 2025 American Society of Clinical Oncology Annual Meeting
April 23, 2025
·
4 min read
Press Releases
Taiho Pharmaceutical, Taiho Oncology, and Cullinan Therapeutics Announce Primary Endpoint Met in Phase 2b Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy
January 28, 2025
·
8 min read
Press Releases
Taiho Oncology to Present Data at the 2025 ASCO Gastrointestinal Cancers Symposium
January 8, 2025
·
3 min read
Biotech Bay
Taiho Ventures Expands Investment Pool to $400 Million to Continue Quality Investments and Accelerate Open Innovation
Taiho Pharmaceutical Co., Ltd. and Taiho Ventures, LLC, a strategic corporate venture capital arm of Taiho Pharmaceutical, announced that Taiho Ventures has increased its investment pool by $100 million from $300 million to $400 million.
January 8, 2024
·
2 min read
Press Releases
Taiho Oncology Announces Decitabine and Cedazuridine to be Included in NIH Precision Medicine Trials
January 15, 2025
·
3 min read
Press Releases
Taiho Oncology Presents Real-World Findings for LONSURF® at the ASCO Gastrointestinal Cancers Symposium
January 24, 2025
·
11 min read
Press Releases
NCCN Announces New Gastrointestinal Cancer Research Grants in Collaboration with Taiho Oncology, Inc.
February 26, 2025
·
4 min read
Press Releases
Taiho Oncology Data at ASH Annual Meeting Highlight Progress in Oral Therapies for Patients with Blood Cancers
December 9, 2024
·
9 min read
1 of 67,223
Next
